Concert Pharmaceuticals, Inc. (CNCE) Q3 2020 Earnings Call Transcript
CNCE earnings call for the period ending September 30, 2020.
Concert Pharmaceuticals
CNCE
CNCE
$10.80
$0.29
2.8%
Price as of January 22, 2021, 9:00 p.m. EST
View Interactive CNCE Charts
CONCERT PHARMACEUT
Interactive Chart
News & Analysis: Concert Pharmaceuticals
Concert Pharmaceuticals, Inc. (CNCE) Q2 2020 Earnings Call Transcript
CNCE earnings call for the period ending June 30, 2020.
Concert Pharmaceuticals, Inc. (CNCE) Q1 2020 Earnings Call Transcript
CNCE earnings call for the period ending March 31, 2020.
Concert Pharmaceuticals, Inc. (CNCE) Q4 2019 Earnings Call Transcript
CNCE earnings call for the period ending December 31, 2019.
Concert Pharmaceuticals, Inc. (CNCE) Q3 2019 Earnings Call Transcript
CNCE earnings call for the period ending September 30, 2019.
Why Concert Pharmaceuticals Stock Is Tanking Today
Shares fall hard after a late-stage trial comes up short.
Concert Pharmaceuticals, Inc. (CNCE) Q2 2019 Earnings Call Transcript
CNCE earnings call for the period ending June 30,2019.
Concert Pharmaceuticals, Inc. (CNCE) Q1 2019 Earnings Call Transcript
CNCE earnings call for the period ending March 31, 2019.
Concert Pharmaceuticals, Inc. (CNCE) Q4 2018 Earnings Conference Call Transcript
CNCE earnings call for the period ending December 31, 2018.
Why Concert Pharmaceuticals, Inc. Is Singing the Blues Today
Bad news trumps good news for the biotech.
